-+ 0.00%
-+ 0.00%
-+ 0.00%

Circio partners with Full Circles Therapeutics on non-viral in vivo cell therapy research

PUBT·08/26/2026 11:17:41
Listen to the news
Circio partners with Full Circles Therapeutics on non-viral in vivo cell therapy research
  • Circio entered a research collaboration with Full Circles Therapeutics to test a combined non-viral platform for in vivo cell therapy.
  • Work will pair Circio’s circVec circular RNA expression technology with Full Circles’ C4DNA cssDNA vectors to target durable, re-dosable expression.
  • Full Circles will manufacture C4DNA vectors carrying circVec inserts; Circio will evaluate delivery, expression, immunogenicity in vitro, in vivo.
  • Partnership targets alternatives to viral vectors, aiming to support in vivo CAR-T approaches with non-integrating, immune-silent DNA delivery.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Circio Holding ASA published the original content used to generate this news brief on August 26, 2026, and is solely responsible for the information contained therein.